This groundbreaking piece from the HESI Cardiac Safety Committee proposes a new alternative approach to preclinical drug safety assessment, using human cell-based models and computational methods to identify human-relevant liabilities earlier in the process.
Challenging the status quo: a framework for mechanistic and human-relevant cardiovascular safety screening
Frontiers in Toxicology, 2024